Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters








Database
Language
Publication year range
1.
Clin Pharmacol Ther ; 89(5): 726-34, 2011 May.
Article in English | MEDLINE | ID: mdl-21451509

ABSTRACT

The safety and pharmacokinetic (PK)/pharmacodynamic (PD) profile of the novel CCR1 antagonist CCX354 was evaluated in double-blind, placebo-controlled, single- and multiple-dose phase I studies (1-300 mg/day oral doses). CCX354 was well tolerated and displayed a linear dose-exposure profile, with half-life approaching 7 h at the 300-mg dose. The extent of CCR1 receptor blockade on blood monocytes, which correlated well with plasma concentrations of the drug, was assessed using fluorescently labeled CCL3 binding in whole blood from phase I subjects. High levels of receptor coverage at the 12-h time point were achieved after a single dose of 100 mg CCX354. Preclinical studies indicate that effective blockade of inflammatory cell infiltration into tissues requires ≥90% CCR1 inhibition on blood leukocytes at all times. The comparison of the properties of CCX354 with those published for other CCR1 antagonists has informed the dose selection for ongoing clinical development of CCX354 in rheumatoid arthritis (RA).


Subject(s)
Inflammation Mediators/pharmacology , Inflammation Mediators/pharmacokinetics , Quinoxalines/pharmacology , Quinoxalines/pharmacokinetics , Receptors, CCR1/antagonists & inhibitors , Adult , Animals , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Inflammation Mediators/administration & dosage , Male , Middle Aged , Monocytes/drug effects , Monocytes/metabolism , Monocytes/pathology , Protein Binding/physiology , Quinoxalines/administration & dosage , Rabbits , Rats , Rats, Wistar , Receptors, CCR1/metabolism , Young Adult
2.
J Bacteriol ; 180(19): 5235-9, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9748460

ABSTRACT

Stalk synthesis in Caulobacter crescentus is a developmentally controlled and spatially restricted event that requires the synthesis of peptidoglycan at the stalk-cell body junction. We show that the beta-lactam antibiotic mecillinam prevents stalk synthesis by inhibiting stalk elongation. In addition, mecillinam causes an increase in the diameter of the stalk at the stalk-cell body junction. We describe two mutations that confer resistance to mecillinam and that prevent stalk elongation. These mutations are probably allelic, and they map to a locus previously not associated with stalk synthesis.


Subject(s)
Amdinocillin/pharmacology , Caulobacter crescentus/drug effects , Penicillin Resistance/genetics , Penicillins/pharmacology , Caulobacter crescentus/genetics , Caulobacter crescentus/growth & development , Mutation , Phenotype
3.
Genetics ; 142(4): 1105-17, 1996 Apr.
Article in English | MEDLINE | ID: mdl-8846891

ABSTRACT

The rad9 gene of Coprinus cinereus is essential for the normal completion of meiosis. We examined surface-spread preparations of wild-type and rad9-1 nuclei from the meiotic stages of karyogamy through metaphase I, and we determined the primary sequence, structure, and meiotic expression of the rad9 gene. In wild-type C. cinereus, karyogamy is followed by condensation and alignment of homologous chromosomes. Condensation and axial core development largely precede synapsis, which often initiates at telomeres. A diffuse diplotene phase coincides with dissolution of the synaptonemal complex, and subsequently chromosomes further condense as the cells progress into metaphase I. In contrast, although karyogamy and nucleolar fusion are apparently normal in rad9-1 basidia, only short stretches of synaptonemal complex form. These correlate with stretches of condensed chromatin, mostly at apparent chromosome ends, and regions of presumptive triple synapsis are numerous. rad9-1 basidia enter the diffuse stage of early diplotene, and then 50% of these cells enter metaphase I by the criteria of nucleolar elimination and at least some chromatin condensation. rad9 gene expression is induced after gamma irradiation and during meiosis. The gene has 27 exons and encodes a predicted protein of 2157 amino acids, with a proline-rich amino terminus.


Subject(s)
Cell Cycle Proteins , Coprinus/genetics , Fungal Proteins/genetics , Meiosis/physiology , Peptides/genetics , Amino Acid Sequence , Base Sequence , Chromosomes, Fungal , Coprinus/ultrastructure , DNA, Fungal , Fungal Proteins/physiology , Genes, Fungal , Molecular Sequence Data , Peptides/physiology , Proline-Rich Protein Domains , Time Factors
4.
Nucleic Acids Res ; 20(15): 3993-9, 1992 Aug 11.
Article in English | MEDLINE | ID: mdl-1354851

ABSTRACT

We have constructed cosmid libraries from electrophoretically separated chromosomes of the basidiomycete Coprinus cinereus. These libraries greatly facilitate the isolation of genes by complementation of mutant phenotypes and are particularly useful for map-based cloning strategies. From a library constructed from two co-migrating C.cinereus chromosomes, we isolated a clone that complements the C.cinereus rad9-1 mutation. Examination of this clone showed that it complements both the repair and meiotic defects of this mutant. Restriction fragment length polymorphism mapping using a portion of this clone showed that it maps to the rad9 locus. In addition, a single copy of transforming DNA is sufficient to complement the rad9-1 defects. Thus, we believe we have cloned the rad9 gene itself. We also used a chromosome-specific library and backcrossed isolates to rapidly identify a cosmid clone which is tightly linked to the rad11 locus and is therefore a suitable starting point for a chromosome walk. These rapid methods of gene mapping and isolation should be applicable to any organism with separable chromosomes.


Subject(s)
Cell Cycle Proteins , Chromosomes, Fungal , Coprinus/genetics , Fungal Proteins/genetics , Polymorphism, Restriction Fragment Length , Cloning, Molecular , Cosmids/genetics , Electrophoresis , Gene Library , Genes, Fungal , Genetic Complementation Test
SELECTION OF CITATIONS
SEARCH DETAIL